• Magnetic Bispecific Nano-Antibodies Enable In Vivo CAR-T Mim

  2026-06-19

  The reference study introduces a magnetic bispecific nano-antibody (M-BiNanoAb) platform that generates and guides CAR-T-mimicking cells in vivo for solid tumor therapy. This approach overcomes key challenges in solid tumor immunotherapy, offering precise T cell targeting and enhanced tumor infiltration without ex vivo genetic manipulation.

• Clozapine N-oxide: Chemogenetic Precision for Neuronal Modul

  2026-06-19

  Clozapine N-oxide (CNO) stands at the forefront of neuroscience research, enabling highly selective and reversible modulation of neuronal circuits via chemogenetics. This article details actionable workflows, experimental tips, and troubleshooting strategies that maximize the potential of CNO as a neuroscience research tool.

• Virus-Mimicking Nanoparticles Enable Extrahepatic mRNA Deliv

  2026-06-18

  This study presents a modular virus-mimicking nanoparticle platform, engineered for precise and efficient delivery of mRNA to extrahepatic tissues. The approach overcomes longstanding barriers of hepatic tropism and immunogenicity, opening new avenues for targeted immunotherapy and gene expression research.

• Applied Cell Counting Kit-8 (CCK-8) Workflows in Cell Viabil

  2026-06-18

  Unlock the full potential of the Cell Counting Kit-8 (CCK-8) for sensitive and reproducible cell viability, proliferation, and cytotoxicity measurements. This guide bridges advanced research insights with hands-on protocol enhancements, troubleshooting strategies, and future outlooks for biomedical applications.

• Ertapenem Sodium Salt: Optimizing Resistance Profiling Workf

  2026-06-17

  Ertapenem sodium salt empowers precise, reproducible profiling of Gram-positive and Gram-negative bacterial resistance, with robust pharmacokinetics and flexible solubility for advanced experimental designs. This guide details hands-on workflows, critical troubleshooting, and key innovations driving next-generation antibiotic resistance research.

• Hoechst 33342 Solution: High-Fidelity Nuclear Stain for Live

  2026-06-17

  Hoechst 33342 is a blue fluorescent nuclear stain with high permeability and low cytotoxicity, enabling precise nuclear visualization in live and fixed cells. The 1 mg/mL solution from APExBIO sets performance benchmarks for both fluorescence microscopy and flow cytometry. This article details mechanistic, protocol, and application findings for robust and reproducible nuclear staining.

• Notch Inhibition Boosts Immune Checkpoint Therapy in TNBC

  2026-06-16

  This study demonstrates that targeting the Notch signaling pathway reshapes the tumor immune microenvironment in triple-negative breast cancer (TNBC), enhancing the efficacy of immune checkpoint blockade. The findings reveal a mechanistic link between Notch-driven cytokine signaling, tumor-associated macrophage recruitment, and immune evasion, suggesting new combinatorial strategies for resistant TNBC.

• EdU Imaging Kits (Cy5): Precision S-Phase Detection for Cell

  2026-06-16

  EdU Imaging Kits (Cy5) redefine cell proliferation analysis with morphology-preserving, click chemistry-based workflow for S-phase DNA synthesis measurement. Optimized for both microscopy and flow cytometry, these kits deliver superior sensitivity and low background, streamlining genotoxicity assessment and advanced stem cell research.

• Ademetionine’s Role in CNS Methylation and Neurological Diso

  2026-06-15

  This review by Bottiglieri et al. synthesizes evidence on the biochemical and neuropharmacological roles of ademetionine (S-adenosylmethionine, SAMe) in the central nervous system, emphasizing its importance in methylation pathways and implications for treating neuropsychiatric and neurodegenerative conditions. The paper’s integrative approach highlights the mechanistic links between methyl donor metabolism, neurotransmitter regulation, and clinical outcomes in disorders such as depression, dementia, and schizophrenia.

• CD146+ Stem Cells Drive Angiogenesis in Lung Cancer Brain Me

  2026-06-15

  This study identifies CD146-positive, pericyte-like cancer stem cells as central drivers of angiogenesis in lung cancer brain metastasis via dual VEGF/VEGFR axis regulation. The findings highlight CD146 as a promising anti-vascular target, challenging current reliance on VEGF-blockade and opening new avenues for anti-angiogenic therapy in resistant metastatic disease.

• gamma-Glu-Cys: Enabling Advanced Glutathione Metabolism Work

  2026-06-14

  gamma-Glu-Cys (γ-Glu-Cys) is a critical substrate that empowers precise, high-yield glutathione metabolism and kokumi peptide engineering. Its high solubility and purity make it indispensable for reproducible workflows in both microbial and plant stress adaptation studies.

• Valemetostat in Relapsed/Refractory Non-Hodgkin Lymphoma: Ph

  2026-06-13

  This phase 1, first-in-human study evaluates the safety and preliminary efficacy of valemetostat, a dual EZH2/EZH1 inhibitor, in patients with relapsed or refractory non-Hodgkin lymphoma. Results demonstrate an acceptable safety profile and meaningful clinical activity, establishing a recommended phase 2 dose and supporting further clinical development.

• Bestatin (Ubenimex): Precision Tools for Aminopeptidase Rese

  2026-06-12

  Bestatin (Ubenimex) has emerged as a benchmark compound for dissecting aminopeptidase biology in cancer and multidrug resistance research. This article delivers a mechanistic perspective—anchored in structural biochemistry and translational strategy—on leveraging Bestatin for advanced apoptosis assays, aminopeptidase activity measurement, and experimental innovation. Integrating crystallographic insights, actionable protocols, and critical evaluation of competitive tools, we offer a forward-looking guide for researchers aiming to translate bench findings into impactful biological discoveries.

• RapaLink-1: Third-Generation mTOR Inhibitor in Cancer & Dorm

  2026-06-12

  RapaLink-1, a third-generation mTOR inhibitor, offers potent inhibition of the PIK3CA–AKT–mTOR pathway and overcomes resistance mutations in cancer and developmental models. Its bivalent mechanism achieves durable mTORC1 blockade and enables pharmacological induction of embryonic dormancy in vitro. Evidence demonstrates superior efficacy over earlier mTOR inhibitors in both tumor regression and cell cycle arrest.

• Estradiol in Research: Protocols, Applications, and Troubles

  2026-06-11

  Estradiol (17 beta-estradiol) is a cornerstone for modeling estrogen receptor signaling and organ protection in perimenopausal research. This guide translates recent breakthroughs into actionable protocols and troubleshooting, leveraging APExBIO’s Estradiol for reliable, reproducible outcomes.

406 records 11/28 page Previous Next First page 上5页 1112131415 下5页 Last page